The Semaglutide peptide has emerged as a compelling subject in biochemical and physiological research due to its potential ...

For adults with obesity and migraine, liraglutide reduces migraine burden, with reductions in mean monthly headache days.

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

A GLP-1 drug led to fewer days with headaches, a small pilot study of migraine sufferers shows. It may work by lowering pressure inside the head.

People with unresponsive chronic migraine and obesity experienced substantial relief after they started taking a GLP-1 drug, researchers in Italy have found.

FIGURE 1. Liraglutide mitigated high glucose-induced RGCs injuries in vitro. As shown in the figure, RGCs were treated with different concentrations of glucose (25, 40, 65, 80, 95, 110 mmol/L) and ...

Objectives To synthesise current evidence for the effects of exenatide and liraglutide on heart rate, blood pressure and body weight. Design Meta-analysis of available data from randomised controlled ...

They have been called miraculous and the fastest way to lose weight. From Wegovy to Mounjaro, here’s how GLP-1 drugs work ...

Among these are the incretin-based therapies, which include glucagon-like peptide (GLP)-1 receptor agonists; this article focuses on one of these agonists, the human GLP-1 analog liraglutide.

Albiglutide, dulaglutide, liraglutide, and semaglutide are more similar, structurally, to native GLP-1, whereas exenatide and lixisenatide are based, structurally, on exendin-4. 24,25 Duration of ...

Researchers at the Headache Center of the University of Naples "Federico II" gave the glucagon-like peptide-1 (GLP-1) ...

GLP-1 drugs are revolutionizing the treatment of obesity and diabetes. Here's what to know about investing in GLP-1 stocks.